Variant report
Variant | nsv548146 |
---|---|
Chromosome Location | chr1:169000109-169006682 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000143153 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10919036 | chr1:169000109-169000110 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs187250096 | chr1:169000112-169000113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs549771736 | chr1:169000120-169000121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571237856 | chr1:169000184-169000185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112121501 | chr1:169000185-169000186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146355712 | chr1:169000193-169000194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs556875841 | chr1:169000255-169000256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs80097353 | chr1:169000281-169000282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs4486430 | chr1:169000292-169000293 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs16861872 | chr1:169000391-169000392 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs568571592 | chr1:169000398-169000399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555254470 | chr1:169000426-169000427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569982447 | chr1:169000486-169000487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs10494476 | chr1:169000494-169000495 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs558556874 | chr1:169000552-169000553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373790985 | chr1:169000594-169000595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114367705 | chr1:169000612-169000613 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs541557748 | chr1:169000627-169000628 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192012360 | chr1:169000644-169000645 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs185301684 | chr1:169000684-169000685 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542421478 | chr1:169000741-169000742 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190540231 | chr1:169000744-169000745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs12404439 | chr1:169000797-169000798 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs377495405 | chr1:169000825-169000826 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs193147465 | chr1:169000854-169000855 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78332061 | chr1:169000859-169000860 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs112984988 | chr1:169000906-169000907 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564913639 | chr1:169000932-169000933 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs77072867 | chr1:169000939-169000940 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs149636845 | chr1:169001025-169001026 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs144256444 | chr1:169001031-169001032 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs184424110 | chr1:169001085-169001086 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs187979511 | chr1:169001106-169001107 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533826444 | chr1:169001115-169001116 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548346077 | chr1:169001132-169001133 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs569893703 | chr1:169001138-169001139 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs537384997 | chr1:169001158-169001159 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs142163836 | chr1:169001186-169001187 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs71118957 | chr1:169001194-169001195 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs75110497 | chr1:169001199-169001200 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73045883 | chr1:169002948-169002949 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs540571640 | chr1:169002983-169002984 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs79514534 | chr1:169002991-169002992 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs186451027 | chr1:169003012-169003013 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs550966379 | chr1:169003022-169003023 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs189734938 | chr1:169003111-169003112 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs558971988 | chr1:169003126-169003127 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs533501678 | chr1:169003232-169003233 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs551844269 | chr1:169003272-169003273 | Inactive region | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs73045884 | chr1:169003294-169003295 | Inactive region | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:168997400-169000800 | Weak transcription | Brain Hippocampus Middle | brain |
2 | chr1:169000000-169000200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr1:169000600-169000800 | Enhancers | Skeletal Muscle Female | skeletal muscle |
4 | chr1:169000600-169001000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr1:169000800-169001000 | Enhancers | Brain Hippocampus Middle | brain |
6 | chr1:169000800-169001000 | Enhancers | Colon Smooth Muscle | Colon |
7 | chr1:169000800-169001000 | Enhancers | Rectal Smooth Muscle | rectum |
8 | chr1:169000800-169001200 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr1:169000800-169001200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
10 | chr1:169000800-169001200 | Enhancers | Brain Inferior Temporal Lobe | brain |
11 | chr1:169000800-169001200 | Enhancers | Brain Substantia Nigra | brain |
12 | chr1:169000800-169001200 | Flanking Active TSS | Skeletal Muscle Female | skeletal muscle |